Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
815 dias atrás
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1081 dias atrás
Euro Rises Against Majors
The euro strengthened against other major currencies in the pre-European session on Thursday.
RTTNews
|
1h 10min atrás
Australian Dollar Rises After Upbeat Jobs Data
The Australian dollar strengthened against other major currencies in the Asian session on Thursday, following the release of Australia's upbeat employment data in October.
RTTNews
|
4h 5min atrás
European Markets Seen Gaining On Thursday
Stock markets in Europe are expected to open higher on Thursday amidst positive sentiment generated by the conclusion of the longest federal closure in U.S. history.
RTTNews
|
4h 42min atrás
Sensex, Nifty Climb Higher On Earnings, Positive Global Cues
After a positive start and a subsequent retreat, BSE benchmark Sensex and the National Stock Exchange's Nifty50 moved higher Thursday morning, with investors picking up stocks, reacting to some encouraging earnings announcements.
RTTNews
|
4h 53min atrás
Australian Dollar Rises Against Majors
The Australian dollar strengthened against other major currencies in the Asian session on Thursday.
RTTNews
|
5h 18min atrás
European Economic News Preview: UK GDP Data Due
Quarterly national accounts from the UK and industrial production from the euro area are the major reports due on Thursday. At 2.00 am ET, the Office for National Statistics releases UK GDP, industrial production and foreign trade data. The economy is forecast to grow 0.2 percent sequentially, slower than the 0.3 percent expansion in the second quarter.
RTTNews
|
5h 25min atrás
